Takemoto S, Terasaki P I, Gjertson D W, Cecka J M
Department of Surgery, UCLA.
N Engl J Med. 1994 Sep 22;331(12):760-4. doi: 10.1056/NEJM199409223311202.
The methods used to allocate cadaveric kidneys in the United States have been criticized as being unfair to minorities because of an over-emphasis on HLA matching. We evaluated a new HLA-matching method that might alleviate this problem.
We used data from the United Network for Organ Sharing (UNOS) Kidney Transplant Registry to evaluate and project the outcome of cadaveric kidney transplantation. An HLA-matching method based on compatibility at 10 key amino acid residues of HLA-A and B molecules and a limited number of HLA-DR types was evaluated with use of the HLA types of the patients currently on the national waiting list and waiting lists in Los Angeles and Birmingham, Alabama.
With national kidney sharing, the projected 10-year rate of graft survival for transplants in which there were no HLA-A, B, or DR mismatches was 66 percent, as compared with 39 percent for transplants with more than two HLA-A, B, or DR mismatches. With local sharing, 43 percent of patients could be fully matched, and they had a projected 10-year graft-survival rate of 50 percent. When one HLA-DR mismatch was allowed, the projected 10-year graft survival was 46 percent, and 67 percent of patients waiting locally could receive such grafts. Even in Alabama, where 68 percent of the patients on the waiting list are black, 48 percent of waiting patients could obtain a matched kidney.
Inserting two new HLA-matching categories into the UNOS point system for cadaveric kidney allocation would increase the number of patients for whom matches could be found in local pools.
在美国,用于分配尸体肾的方法因过度强调人类白细胞抗原(HLA)配型而被批评对少数族裔不公平。我们评估了一种可能缓解这一问题的新HLA配型方法。
我们使用器官共享联合网络(UNOS)肾移植登记处的数据来评估和预测尸体肾移植的结果。采用目前在全国等待名单以及洛杉矶和阿拉巴马州伯明翰等待名单上患者的HLA类型,评估了一种基于HLA - A和B分子10个关键氨基酸残基兼容性以及有限数量HLA - DR类型的HLA配型方法。
在全国肾脏共享中,预计无HLA - A、B或DR错配的移植肾10年生存率为66%,而有超过两个HLA - A、B或DR错配的移植肾10年生存率为39%。在本地共享中,43%的患者可以完全匹配,他们预计的10年移植肾生存率为50%。当允许一个HLA - DR错配时,预计的10年移植肾生存率为46%,67%在本地等待的患者可以接受这样的移植肾。即使在阿拉巴马州,等待名单上68%的患者是黑人,48%等待的患者也可以获得匹配的肾脏。
在UNOS尸体肾分配积分系统中增加两个新的HLA配型类别,将增加在本地库中找到匹配肾脏的患者数量。